| Acceptance rate | 46% |
|---|---|
| Time to first decision | 6 months* |
| Time to decision with review | 50 days* |
*Approximate number of days
**The days mentioned above are averages and do not indicate exact durations. The process may vary for each article.
ACTA Pharmaceutica Sciencia
2023 , Vol 61 , Num 2
Evaluation of venous thromboembolism prophylaxis in cancer patients: a retrospective study
1 Department of Clinical Pharmacy, School of Pharmacy, İstanbul Medipol University, İstanbul,TürkiyeDOI : 10.23893/1307-2080.APS6114 Viewed : 7185 - Downloaded : 2329 Keywords :